EDGAR Filing Documents for 0001104659-16-146426

Form 8-K - Current report:

SEC Accession No. 0001104659-16-146426

Filing Date

2016-09-26

Accepted

2016-09-26 08:10:53

Documents

Period of Report

2016-09-23

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a16-19020_18k.htm	8-K	47103
2	EX-4.1	a16-19020_1ex4d1.htm	EX-4.1	1042761
3	EX-99.1	a16-19020_1ex99d1.htm	EX-99.1	14310
4	GRAPHIC	g190201mmi001.jpg	GRAPHIC	2840
5	GRAPHIC	g190201mmi002.jpg	GRAPHIC	2966
6	GRAPHIC	g190201kg33i001.jpg	GRAPHIC	2814
7	GRAPHIC	g190201kg33i002.jpg	GRAPHIC	2608
	Complete submission text file	0001104659-16-146426.txt		1121430

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142

Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722

IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 161901215
SIC: 2834 Pharmaceutical Preparations